Načítá se...
Clinical Potential of Mass Spectrometry-based Proteogenomics
Cancer genomics research aims to advance personalized oncology by finding and targeting genetic alterations associated with cancers. In genome-driven oncology, treatments are selected for individual patients based on the genomic sequence of their tumor. This personalized oncology approach has prolon...
Uloženo v:
| Vydáno v: | Nat Rev Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448780/ https://ncbi.nlm.nih.gov/pubmed/30487530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-018-0135-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|